Nebenwirkungen · Thyrogen
Thyrogen 0.9 mg powder for solution for injection · Abschnitt 4.8 · PDF-Seite 6
HOS-089149 · Präparat HOS-083791
Enlargement of residual thyroid tissue or metastases can occur following treatment with Thyrogen. This may lead to acute symptoms, which depend on the anatomical location of the tissue. For example, hemiplegia, hemiparesis or loss of vision have occurred in patients with CNS metastases. Laryngeal oedema, respiratory distress requiring tracheotomy, and pain at the site of metastasis have also been reported after Thyrogen administration. It is recommended that pre-treatment with corticosteroids be considered for patients in whom local tumour expansion may compromise vital anatomic structures.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-02-19T15:41:00Z · SHA-256 4c0692bbebbd5e3c37ecde6ff75fce3b0796948616084ad7890ad9b1231d1ec1 · Passage 616e4160cde82a621cd71731fb8eba5873a7523810c53ce81d548cc2a99ec1fd · Zeichen 3804–4401 im Abschnitt